ORTOMA AB B (82Y) - Total Liabilities
Based on the latest financial reports, ORTOMA AB B (82Y) has total liabilities worth €18.63 Million EUR (≈ $21.78 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See 82Y working capital ratio to evaluate short-term liquidity relative to the company's equity base.
ORTOMA AB B - Total Liabilities Trend (2021–2025)
This chart illustrates how ORTOMA AB B's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see 82Y total assets.
ORTOMA AB B Competitors by Total Liabilities
The table below lists competitors of ORTOMA AB B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Century Lithium Corp.
V:LCE
|
Canada | CA$184.90K |
|
Maquia Capital Acquisition Corp
NASDAQ:MAQC
|
USA | $9.56 Million |
|
Aarey Drugs & Pharmaceuticals Limited
NSE:AAREYDRUGS
|
India | Rs1.45 Billion |
|
Medico Remedies Limited
NSE:MEDICO
|
India | Rs779.29 Million |
|
Jeil Steel Mfg Co. Ltd
KQ:023440
|
Korea | ₩60.19 Billion |
|
Dusk Group Ltd
AU:DSK
|
Australia | AU$54.92 Million |
|
TDb Split Corp
TO:XTD
|
Canada | CA$47.56 Million |
|
MFS Investment Grade Municipal Trust
NYSE:CXH
|
USA | $44.83 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down ORTOMA AB B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See ORTOMA AB B balance sheet quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.19 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ORTOMA AB B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ORTOMA AB B (2021–2025)
The table below shows the annual total liabilities of ORTOMA AB B from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €18.63 Million ≈ $21.78 Million |
-2.35% |
| 2024-12-31 | €19.07 Million ≈ $22.30 Million |
+1.48% |
| 2023-12-31 | €18.80 Million ≈ $21.97 Million |
-49.23% |
| 2022-12-31 | €37.02 Million ≈ $43.28 Million |
+836.96% |
| 2021-12-31 | €3.95 Million ≈ $4.62 Million |
-- |
About ORTOMA AB B
Ortoma AB (publ) provides orthopedic surgical products in Sweden. It offers Ortoma Treatment Solution (OTS), an orthopedic digital, server-based integrated AI platform designed to optimize patient outcomes through surgical planning, precision surgical navigation, post-operative verification, and follow-up; OTS Plan, a software that processes and assists surgeons during pre-operative planning and … Read more